|
Volumn 24, Issue 11, 2009, Pages 3284-3285
|
Coumarin use in dialysis patients with atrial fibrillation-more harm than benefit
|
Author keywords
Atrial fibrillation; Haemodialysis; Warfarin
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIVITAMIN K;
COUMARIN;
WARFARIN;
ANTICOAGULANT AGENT;
COUMARIN DERIVATIVE;
VITAMIN K GROUP;
BLEEDING;
BLOOD VESSEL CALCIFICATION;
CALCINOSIS;
CLINICAL FEATURE;
HEART ATRIUM FIBRILLATION;
HEMODIALYSIS;
HUMAN;
MEDICAL SOCIETY;
MORBIDITY;
MORTALITY;
NONHUMAN;
NOTE;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
RISK FACTOR;
STROKE;
THROMBOEMBOLISM;
ANIMAL;
ARTICLE;
MOUSE;
QUALITY ADJUSTED LIFE YEAR;
RENAL REPLACEMENT THERAPY;
ANIMALS;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
CALCINOSIS;
COUMARINS;
HUMANS;
MICE;
QUALITY-ADJUSTED LIFE YEARS;
RENAL DIALYSIS;
VITAMIN K;
|
EID: 73949120438
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfp368 Document Type: Note |
Times cited : (12)
|
References (8)
|